MEDICENNA THERAPEUTICS CORP (MDNA.CA) Stock Income Statement
TSX:MDNA - CA58490H1073 - Common Stock
1.09 CAD
+0.04 (+3.81%)
| TTM (2025-6-30) | 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 21.88M | 20.41M | 18.67M | 16.30M | 22.47M | |||
| Research and Development | 15.87M | 14.44M | 10.80M | 9.30M | 16.47M | |||
| Selling, General, and Administrative Expenses | 5.94M | 5.91M | 7.87M | 6.99M | 7.72M | |||
| Operating Income | -21.88M | -20.41M | -18.67M | -16.30M | -22.47M | |||
| Interest Income/Expense | 8.78M | 8.60M | -6.79M | 6.26M | -100.00K | |||
| Other Income/Expense | N/A | N/A | 0.00 | N/A | 104.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -13.10M | -11.80M | -25.47M | -10.05M | -22.58M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -13.10M | -11.80M | -25.47M | -10.05M | -22.58M | |||
| EBITDA | -21.81M | -20.35M | -18.67M | N/A | -22.43M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.17 | -0.15 | -0.37 | -0.16 | -0.42 | |||
| Non GAAP EPS | -0.16 | -0.15 | -0.36 | -0.19 | -0.42 | |||
| Statistics | ||||||||
All data in CAD